- SGMO has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $16.9 million.
- SGMO has traded 185,059 shares today.
- SGMO is down 3.2% today.
- SGMO was up 17.5% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in SGMO with the Ticky from Trade-Ideas. See the FREE profile for SGMO NOW at Trade-Ideas More details on SGMO: Sangamo BioSciences, Inc., a clinical stage biopharmaceutical company, focuses on the research, development, and commercialization of zinc finger DNA-binding proteins (ZFPs) for gene regulation and gene modification in the United States. Currently there are 4 analysts that rate Sangamo BioSciences a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Sangamo BioSciences has been 786,400 shares per day over the past 30 days. Sangamo BioSciences has a market cap of $898.1 million and is part of the health care sector and drugs industry. The stock has a beta of 2.73 and a short float of 16.4% with 9.41 days to cover. Shares are up 1.3% year-to-date as of the close of trading on Thursday.